| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment - United States, July 2022-September 2023.
Reported Xylazine Use Among Adults Aged ≥18 Years Evaluated for Substance Use Treatment - United States, July 2022-September 2023.
Jiang X, Connolly S, Strahan AE, Rivera Blanco L, Mikosz CA, Guy GP Jr, Dowell D.
MMWR Morb Mortal Wkly Rep. 2024 Jul 4;73(26):594-599. doi: 10.15585/mmwr.mm7326a2. PMID: 38959171; PMCID: PMC11221633.